Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Feb;34(2):2011-2023.
doi: 10.1096/fj.201902063R. Epub 2019 Dec 12.

SHIP-1, a target of miR-155, regulates endothelial cell responses in lung fibrosis

Affiliations

SHIP-1, a target of miR-155, regulates endothelial cell responses in lung fibrosis

Haiying Tang et al. FASEB J. 2020 Feb.

Abstract

Src Homology 2-containing Inositol Phosphatase-1 (SHIP-1) is a target of miR-155, a pro-inflammatory factor. Deletion of the SHIP-1 gene in mice caused spontaneous lung inflammation and fibrosis. However, the role and function of endothelial miR-155 and SHIP-1 in lung fibrosis remain unknown. Using whole-body miR-155 knockout mice and endothelial cell-specific conditional miR-155 (VEC-Cre-miR-155 or VEC-miR-155) or SHIP-1 (VEC-SHIP-1) knockout mice, we assessed endothelial-mesenchymal transition (EndoMT) and fibrotic responses in bleomycin (BLM) induced lung fibrosis models. Primary mouse lung endothelial cells (MLEC) and human umbilical vein endothelial cells (HUVEC) with SHIP-1 knockdown were analyzed in TGF-β1 or BLM, respectively, induced fibrotic responses. Fibrosis and EndoMT were significantly reduced in miR-155KO mice and changes in EndoMT markers in MLEC after TGF-β1 stimulation confirmed the in vivo findings. Furthermore, lung fibrosis and EndoMT responses were reduced in VEC-miR-155 mice but significantly enhanced in VEC-SHIP-1 mice after BLM challenge. SHIP-1 knockdown in HUVEC cells resulted in enhanced EndoMT induced by BLM. Meanwhile, these changes involved the PI3K/AKT, JAK/STAT3, and SMAD/STAT signaling pathways. These studies demonstrate that endothelial miR-155 plays an important role in fibrotic responses in the lung through EndoMT. Endothelial SHIP-1 is essential in controlling fibrotic responses and SHIP-1 is a target of miR-155. Endothelial cells are an integral part in lung fibrosis.

Keywords: endothelial-mesenchymal transition; lung fibrosis; miR-155; phosphatase SHIP-1.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.. Endothelial-mesenchymal transition (EndoMT) was involved in BLM-induced lung fibrosis.
(A) Hematoxylin and eosin (H&E) and Masson’s Trichrome stained lung sections from WT mice with BLM challenge or NS control for 28 days (WT-NS, WT-BLM, n=7–8 mice/group). (B) Q-PCR analysis of α-SMA and VE-cadherin mRNA in the lung tissues of WT-NS and WT-BLM mice. Results are Means±SEM from triplicate samples of 3 repeats. (C) Western blot of α-SMA and VE-cadherin proteins in the lung tissues of WT-NS and WT-BLM mice. HSP-90 was used for sample loading control. Shown are representative blots of 3 independent experiments. (D) Immunofluorescence of CD31 and α-SMA in WT-NS and WT-BLM lung tissues and (E) Immunofluorescence of VE-Cadherin and α-SMA in WT-NS and WT-BLM lung tissues. Images were from different animals (n=7–8 mice/group). DAPI stained for nuclei (blue). *p<0.05, **p<0.01.
Figure 2.
Figure 2.. Deletion of MiR-155 alleviated fibrotic and EndoMT responses.
(A) H&E and Trichrome stained lung sections from WT and miR-155−/− mice with BLM stimulation for 28 days (WT-BLM, MiR-155−/−-BLM, n=6–8 mice/group). (B) Hydroxyproline content in the lung tissues of WT and miR-155−/− mice challenged with NS or BLM (n=6–8 mice/group). (C) Q-PCR of Collagen I mRNA in WT and MiR-155−/− lung tissues after NS or BLM challenge. Results are presented as Means±SEM of triplicates of 3 repeats. (D, E) Western blots of α-SMA, Collagen I and VE-cadherin in the lung tissues of WT and miR-155−/− mice with or without BLM. HSP-90 or β-Actin as loading controls. Shown are representative blots of 3 independent experiments. (F) Immunofluorescence of CD31 and α-SMA in WT-BLM and miR-155−/−-BLM lung tissues. Images were from different aniamls (n=6–8 mice/group). (G) Immunofluorescence of VE-Cadherin and α-SMA in WT-BLM and miR-155−/−-BLM lung tissues (n=6–8 mice/group). DAPI for nuclei (blue). *p<0.05; **p<0.01.
Figure 3.
Figure 3.. Role of endothelial MiR-155 in lung fibrosis.
(A, B) Q-PCR of Fibronectin and VE-cadherin mRNA in isolated MLEC from WT and MiR-155KO mice. Results are Mean±SEM of triplicates with 3 repeats. (C) Western blot of α-SMA, Vimentin and VE-cadherin in isolated WT and MiR-155KO MLEC stimulated with TGF-β1 for 72 hrs. Shown are representative blots from 3 independent experiments. (D, E) Immunofluorescence of CD31, Vimentin, VE-Cadherin, and α-SMA in MLEC after stimulation with TGF-β1. Results reprensent 3 independent experiments. (F) H&E and Trichrome staining of lung sections of WT and VEC-miR155 mice after BLM for 28 days (n=6–8 mice/group). (G) Q-PCR of Collagen I mRNA in WT and VEC-miR155 mouse lungs with or without BLM. Results are Mean±SEM of triplicates with 3 repeats. (H) Western blot of Collagen I, α-SMA and VE-cadherin in WT and VEC-miR155 mouse lungs. Shown are representative blots of 3 independent experiments. (I) Immunofluorescence of VE-Cadherin and α-SMA in WT and VEC-miR155 mouse lungs (n=6–8 mice/group). DAPI for nuclei (blue). *p<0.05; **p<0.01.
Figure 4.
Figure 4.. Lack of endothelial SHIP-1 facilitated lung fibrosis and EndoMT in vivo.
(A) Western blot of SHIP-1 in miR-155−/−, VEC-miR-155 and WT mouse lungs before and after BLM challenge for 28 days (n=6 mice/group). (B) Immunoprecipitation (IP) and Western blot (IB) of SHIP-1 protein in HUVEC. Shown are representative results of 3 independent experiments. (C) Q-PCR of SHIP-1 mRNA in mouse lung endothelial cells (MLECs) from WT and VEC-miR155 mice before TGF-β1 stimulation. Results are Mean±SEM of triplicates with 3 repeats. (D) Western blot of SHIP-1 in MLECs from miR-155−/−, WT and VEC-SHIP-1 mice before and after TGF-β1 stimulation for 72 hrs. Results represent 3 independent experiments. (E) H&E and Trichrome stained lung sections from WT and VEC-Cre-SHIP-1 (VEC-SHIP-1) mice after BLM challenge for 28 days (n=7–8 mice/group). (F) Q-PCR of Collagen I and VE-cadherin mRNA in WT and VEC- SHIP-1 mouse lungs. Results are Mean±SEM of triplicates with 3 repeats. (G) Western blot of Collagen I and α-SMA in WT and VEC-SHIP-1 mouse lung tissues and (H) Western blot of α-SMA and VE-cadherin in WT and VEC-SHIP-1 mouse lung tissues. Blots are representative results of 3 independent experiments. (I) Immunofluorescence of VE-Cadherin and α-SMA in WT and VEC-SHIP-1 mouse lung sections. Images were from different animals (n=6–8 mice/group). DAPI for nuclei (blue). *p<0.05; **p<0.01.
Figure 5.
Figure 5.. Effect of endothelial SHIP-1 on TGF-β1-induced EndoMT in vitro.
(A) Flow cytometry analysis of CD31 and SHIP-1 expression in isolated lung cells from WT and VEC-SHIP-1 mice. Upper right panels show the percentage of CD31 and SHIP-1 double positive cells. Results represent 3 independent experiments. (B) Western blot of SHIP-1 expression in WT and VEC-SHIP-1 mouse lung endothelial cells (MLECs). Shown is a representative blot of 3 separate experiments. (C) Immunofluorescence of VE-Cadherin and α-SMA in WT and VEC-SHIP-1 MLECs and (D) Immunofluorescence of CD31 and Vimentin in WT and VEC-SHIP-1 MLECs. Images were taken from 3 independent experiments. (E) Western blot of VE-Cadherin, α-SMA and Vimentin in WT and VEC-SHIP-1 MLECs with or without TGF-β1 stimulation for 72 hrs. Shown are representative results of 3 independent experiments. (F) Western blot of CD31 and α-SMA in primary HUVECs treated with siRNA to SHIP-1 or scrambled siRNA and with/without BLM for 72 hrs. Shown are representative results of 3 independent experiments.
Figure 6.
Figure 6.. Endothelial miR-155 and SHIP-1 in pulmonary fibrosis involving PI3K/AKT, STAT3 and SMAD2/3 signaling pathways.
(A) Western blot of PI3K, p-AKT-1, Twist and Snail in WT and miR-155KO mouse lung tissues after BLM challenge for 28 days (n=6–8/group). (B) Expression of STAT3, Smad2/3 as well as activation of p-STAT3, p-Smad2, and p-Smad3 were detected by Western blot in WT and miR-155KO mice lung tissues (n=6–8/group). (C) Western blot of PI3K, p-PI3K, p-AKT-1, Twist and Snail in WT and VEC-miR-155 mice lung tissues (n=6–8/group). (D) Expression of STAT3 as well as activation of p-STAT3, p-Smad2, and p-Smad3 in WT and VEC-miR-155 mouse lung tissues were analyzed by Western blot (n=6–8/group). (E) Protein expression of PI3K, Twist, Snail as well as activation of p-PI3K, and p-AKT1 in WT and VEC-SHIP-1 mouse lung tissues (n=6–8/group). (F) Western blot of p-STAT3, STAT3, p-SMAD2 and p-SMAD3 in WT and VEC-SHIP-1 mouse lung tissues (n=6–8/group).

Similar articles

Cited by

References

    1. Eramo MJ, and Mitchell CA (2016) Regulation of PtdIns(3,4,5)P3/Akt signalling by inositol polyphosphate 5-phosphatases. Biochem Soc Trans 44, 240–252 - PubMed
    1. Fernandes S, Srivastava N, Sudan R, Middleton FA, Shergill AK, Ryan JC, and Kerr WG (2018) SHIP1 Deficiency in Inflammatory Bowel Disease Is Associated With Severe Crohn’s Disease and Peripheral T Cell Reduction. Front Immunol 9, 1100. - PMC - PubMed
    1. Helgason CD, Damen JE, Rosten P, Grewal R, Sorensen P, Chappel SM, Borowski A, Jirik F, Krystal G, and Humphries RK (1998) Targeted disruption of SHIP leads to hemopoietic perturbations, lung pathology, and a shortened life span. Genes Dev 12, 1610–1620 - PMC - PubMed
    1. Liu Q, Oliveira-Dos-Santos AJ, Mariathasan S, Bouchard D, Jones J, Sarao R, Kozieradzki I, Ohashi PS, Penninger JM, and Dumont DJ (1998) The inositol polyphosphate 5-phosphatase ship is a crucial negative regulator of B cell antigen receptor signaling. J Exp Med 188, 1333–1342 - PMC - PubMed
    1. Oh SY, Zheng T, Bailey ML, Barber DL, Schroeder JT, Kim YK, and Zhu Z (2007) Src homology 2 domain-containing inositol 5-phosphatase 1 deficiency leads to a spontaneous allergic inflammation in the murine lung. J Allergy Clin Immunol 119, 123–131 - PMC - PubMed

Publication types

MeSH terms

-